Public Health & Policy
Stem Cell Research
- By the Numbers
- Clinical Trials
- Environmental Health
- Equity in Medicine
- Ethics
- FDA General
- General Professional Issues
- Health Policy
- Medicaid
- Medical Education
- Medicare
- Military Medicine
- Opioids
- Practice Management
- Product Alert
- Public Health
- Repeal and Replace
- Stem Cell Research
- Washington Watch
- Work Force
More in Stem Cell Research
Agency says PalinGen products are unapproved drugs
Agency says adipose-derived stem cell treatment should be regulated as a drug and biologic
In Australia and Canada, most companies disappeared from the market or changed their claims
Two federal court decisions now hold that fat-derived stem cell treatment is a drug
20 patients became ill after receiving contaminated umbilical cord stem cell products
Agency says Neobiosis amniotic fluid, umbilical cord products should be regulated as drugs
Attorneys general in several states have sued businesses for false claims
Stromal vascular fraction isn't usually sourced from donors
Ray Anthony Shoulders, PA, faces up to 240 years in prison
FDA tells MiMedx that its wound-healing product must be regulated as a biologic drug
Prices are high but evidence is scant that therapies work, researchers say
A podcast, Netflix series, and TV adaptation examine regenerative medicine doctor's wrongdoings
Agency sent warning letter to Regenative Labs over its Wharton's jelly product
First two recipients show dramatic reductions in seizure frequency
